학술논문
Distinguishing the pros and cons of metabolic reprogramming in oncolytic virus immunotherapy.
Document Type
Article
Author
Source
International Journal of Cancer; Nov2022, Vol. 151 Issue 10, p1654-1662, 9p
Subject
Language
ISSN
00207136
Abstract
Copyright of International Journal of Cancer is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)